Clinical Quiz: ACG Guidelines for Treating Helicobacter Pylori Infection

Author(s):

Key Takeaways

Helicobacter pylori is a major cause of dyspepsia, peptic ulcers, and gastric cancer, and is a group I carcinogen.
Recent advancements in testing focus on antibiotic sensitivity profiles and confirming eradication post-treatment.
The American College of Gastroenterology released updated guidelines for managing H. pylori infection in North America.

Test your knowledge of the 2024 American College of Gastroenterology H. pylori management guidelines with this clinical quiz!

HCPLive Clinical Quiz

Helicobacter pylori is a prevalent, global infectious disease that causes dyspepsia, peptic ulcer disease, and gastric cancer. Beyond being one of the most common chronic bacterial infections of humans worldwide, it is also the leading cause of infection-associated cancer, categorized as a group I (definite) carcinogen by the World Health Organization International Agency for Research on Cancer because of its known causal association with gastric cancer.

Although diagnostic testing for H. pylori has been reviewed in previous guidelines with minimal new data since their publication, testing for H. pylori antibiotic sensitivity profiles and post-treatment testing to confirm H. pylori eradication have seen recent advances. To inform the evidence-based management of patients with H. pylori infection based on these updates, the American College of Gastroenterology released a clinical practice guideline on the treatment of H. pylori infection in North America.

Test your knowledge of the guidelines with this clinical quiz!

Which therapy is suggested for treatment-naive patients when clarithromycin susceptibility is unknown?

Reference

Chey, WD, Howden, CW, Moss SF, et al. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. The American Journal of Gastroenterology 119(9):p 1730-1753, September 2024. doi:10.14309/ajg.0000000000002968